Important News and Information FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma 05/02/2020 |
Connecticut Oncology Association (CtOA)
c/o Dawn Holcombe
33 Woodmar Circle
South Windsor, CT 06074
(860) 305-4510
Website design by Sister Webs Design Studio, where 5% of profits are donated to women's cancer funds